Discover Better Designs, Faster.

Multidisciplinary Simulation for Life Sciences

Faced with unprecedented changes in the way new medicines and medical technologies are developed, the healthcare sector is increasingly turning towards digital twins to reduce costs, mitigate risks, and foster innovation. STAR-CCM+ is key in enabling better medicines, superior medical products and significantly improved outcomes for patients.

Learn More

Realizing Innovation in Life Sciences

Find out how the groundbreaking capabilities offered by multidisciplinary simulation and design exploration are changing the face of life sciences.


Our innovative productivity tools and effective solutions are tailored for biomedical and pharmaceutical engineers, and enable them to effortlessly discover better medicines, design superior products and significantly improve patient outcome.

Click on an icon to learn more.

Through simulation-based product development and virtual prototyping, STAR-CCM+ allows you to predict device and drug performance and to drive innovative designs, bringing superior products to market quickly and at reduced costs, and resulting in fewer invasive procedures.

Numerical Diagnostics is aimed at finding the cause of a disease, predicting its progression and making treatment decisions through simulations. STAR-CCM+ can be used to provide key diagnostic help in hospitals, and assist doctors in making difficult clinical decisions.

STAR-CCM+ is a game changer for continuous manufacturing applied to active pharmaceutical ingredients (APIs), leading to shortened product-process development cycles, reduced energy requirements, better quality products and shorter time-to-market.

In Depth

Fostering Medical and Pharmaceutical Innovation with Numerical Simulation

STAR-CCM+ brings unprecedented flexibility and insight to the life sciences industry

In recent years, the US Food and Drug Administration (FDA) has increasingly recognized simulation-based product development and virtual prototyping as valid tools to supplement experimental testing and clinical trials, and accelerate regulatory approval. Initiatives such as the ASME V&V 40, MDIC, or Avicenna, drive and guide these efforts and lobby for the increased usage of simulation for the support of benchtop and clinical trials in the medical device industry. Similarly, in pharma, the move from batch to continuous manufacturing is being promoted by consortia like CSOPS. 

This represents a great opportunity to integrate the use of simulation early when redesigning processes, offering the best possible chance of maximizing ROI. Yet, with the advancement of simulation technology, and following the buy-in and support by the regulatory bodies, the most essential ingredients — expertise and manpower — must come from the customer.

The leading medical device design and pharmaceutical companies have realized that investment is critical, in terms of recruitment as well as technology. They have started integrating simulation into clinical trial studies and are applying it to modernize their manufacturing processes. They are also reaching out to experienced end-users in the automotive and chemical & process industries to help overhaul process engineering in big pharmaceutical firms and integrate new design and testing modalities within medical device companies. 

Better designs, faster

With STAR-CCM+, the shared vision of virtual biomed and pharma labs becomes reality. We are continuously delivering state-of-the-art technologies and automated workflows to help close the gap between experiments, benchtop tests, clinical trials and engineering design. Our capabilities today allow our customers to look at very complex physics and geometries and enable an application range from medical device design all the way to pharmaceutical manufacturing processes.

Case Studies

Don't Just Simulate, Innovate!

See how our customers have been using our products to improve biomedical products, pharmaceutical processes and patient diagnostics.